Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol

被引:41
作者
Mucalo, Iva [1 ]
Hadziabdic, Maja Ortner [1 ]
Brajkovic, Andrea [1 ]
Lukic, Sonja [2 ]
Maric, Patricia [2 ]
Marinovic, Ivana [3 ]
Bacic-Vrca, Vesna [1 ,3 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Ctr Appl Pharm, A Kovacica 1, Zagreb 10000, Croatia
[2] Univ Zagreb, Fac Pharm & Biochem, A Kovacica 1, Zagreb 10000, Croatia
[3] Univ Hosp Dubrava, Dept Clin Pharm, Av Gojka Suska 6, Zagreb 10000, Croatia
关键词
Polypharmacy; Potentially inappropriate medicines; EU(7)-PIM list; STOPP version 2 criteria; Comprehensive protocol; ADVERSE DRUG-REACTIONS; EMERGENCY-DEPARTMENT VISITS; MEDICATION USE; OLDER-ADULTS; BEERS CRITERIA; SCREENING TOOL; CONSENSUS PANEL; STOPP/START CRITERIA; EXPLICIT CRITERIA; GENERAL-PRACTICE;
D O I
10.1007/s00228-017-2246-y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to measure the prevalence of potentially inappropriate medications (PIMs) by using the EU(7)-PIM list, STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions) version 2 criteria and the new comprehensive protocol. This prospective study involved a sample of 276 consecutive elderly patients discharged from the university teaching hospital. Age, gender, diagnoses, medication history and medicines at discharge were recorded. The main outcome measure was the prevalence of PIMs according to each set of criteria: EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. The median patient age (range) was 74 (65-92) years. The median number of prescribed medications was 7 (1-17). STOPP identified 393 PIMs affecting 190 patients (69%), EU(7)-PIM list identified 330 PIMs in 184 patients (66.7%) whilst the comprehensive protocol identified 134 PIMs in 102 patients (37%). STOPP version 2 criteria identified significantly more PIMs per patient than the other two protocols (p < 0.001). Gender (p = 0.002), glomerular filtration rate (p = 0.039) and number of comorbidities (p = 0.001) were associated with the proportion of PIMs for the STOPP version 2 criteria only. A very high PIM prevalence at discharge was reported suggesting the urgent need for actions to reduce them. STOPP version 2 criteria identified significantly more PIMs than the EU(7)-PIM list and the comprehensive protocol and was found as a more sensitive tool for PIM detection.
引用
收藏
页码:991 / 999
页数:9
相关论文
共 50 条
  • [31] Factors associated with the use of potentially inappropriate medications by older adults in primary health care: An analysis comparing AGS Beers, EU (7)-PIM List, and Brazilian Consensus PIM criteria
    Almeida, Thiago Augusto
    Reis, Edna Afonso
    Leite Pinto, Isabela Vaz
    Braga Ceccato, Maria das Gracas
    Silveira, Micheline Rosa
    Lima, Marina Guimaraes
    Moreira Reis, Adriano Max
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (04) : 370 - 377
  • [32] Potentially inappropriate medications according to STOPP-J criteria and risks of hospitalization and mortality in elderly patients receiving home-based medical services
    Huang, Chi-Hsien
    Umegaki, Hiroyuki
    Watanabe, Yuuki
    Kamitani, Hiroko
    Asai, Atushi
    Kanda, Shigeru
    Nomura, Hideki
    Kuzuya, Masafumi
    PLOS ONE, 2019, 14 (02):
  • [33] Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care
    Daniela A. Rodrigues
    Maria Teresa Herdeiro
    Ramona Mateos-Campos
    Adolfo Figueiras
    Fátima Roque
    European Journal of Clinical Pharmacology, 2024, 80 : 603 - 612
  • [34] Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care
    Rodrigues, Daniela A.
    Herdeiro, Maria Teresa
    Mateos-Campos, Ramona
    Figueiras, Adolfo
    Roque, Fatima
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (04) : 603 - 612
  • [35] Availability and actual use in the Belgian market of potentially inappropriate medications (PIMs) from the EU(7)-PIM list
    Wauters, Maarten
    Elseviers, Monique
    Azermai, Majda
    Vander Stichele, Robert
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (02) : 243 - 245
  • [36] Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria
    Gallagher, P. F.
    O'Connor, M. N.
    O'Mahony, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 845 - 854
  • [37] Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study
    Birgit A. Damoiseaux-Volman
    Stephanie Medlock
    Kimmy Raven
    Danielle Sent
    Johannes A. Romijn
    Nathalie van der Velde
    Ameen Abu-Hanna
    European Journal of Clinical Pharmacology, 2021, 77 : 777 - 785
  • [38] Potentially inappropriate prescribing according to STOPP-2 criteria among patients discharged from Internal Medicine: prevalence, involved drugs and economic cost
    Jose Pardo-Cabello, Alfredo
    Manzano-Gamero, Victoria
    Zamora-Pasadas, Monica
    Gutierrez-Cabello, Francisco
    Esteva-Fernandez, David
    de Dios Luna-Del Castillo, Juan
    Jimenez-Alonso, Juan
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2018, 74 : 150 - 154
  • [39] Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria: MoPIM multicentre cohort study
    Marisa Baré
    Marina Lleal
    Sara Ortonobes
    Maria Queralt Gorgas
    Daniel Sevilla-Sánchez
    Nuria Carballo
    Elisabet De Jaime
    Susana Herranz
    BMC Geriatrics, 22
  • [40] Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria: MoPIM multicentre cohort study
    Bare, Marisa
    Lleal, Marina
    Ortonobes, Sara
    Gorgas, Maria Queralt
    Sevilla-Sanchez, Daniel
    Carballo, Nuria
    De Jaime, Elisabet
    Herranz, Susana
    BMC GERIATRICS, 2022, 22 (01)